betway必威登陆网址 (betway.com )学报››2022,Vol. 43››Issue (10): 734-739.DOI:10.3969/j.issn.2097-0005.2022.10.003
黄向业1(), 张茜2, 孙方利3, 李金光1, 赵静4(
)
收稿日期:
2022-05-11出版日期:
2022-10-25发布日期:
2022-11-19通讯作者:
赵静作者简介:
黄向业,博士,主治医师,研究方向:中西医治疗骨关节及腰椎退行性疾病, E-mail:hxye1984@163.com。基金资助:
Xiangye HUANG1(), Qian ZHANG2, Fangli SUN3, Jinguang LI1, Jing ZHAO4(
)
Received:
2022-05-11Online:
2022-10-25Published:
2022-11-19Contact:
Jing ZHAO摘要:
目的探讨白细胞介素-6基因的单核苷酸多态性与腰椎间盘突出症及腰椎退变程度的相关性。方法采用病例-对照研究方法,随机选择腰椎间盘突出症患者321例和非腰椎间盘突出症患者361例,应用TaqMan探针技术对IL-6启动区基因-572C/G、-174G/C位点进行单核苷酸多态性检测,分析比较腰椎间盘突出症组(病例组)和非腰椎间盘突出症组(对照组)之间IL-6基因多态性与腰椎间盘突出症发病的相关性;根据MRI影像表现评估椎间盘退变程度,分析IL-6基因多态性与腰椎间盘退变的相关性。结果IL-6-572C/G基因型在病例组(CC 51.71%、CG 42.37%、GG 5.92%)和对照组(CC 64.27%、CG 34.07%、GG 1.62%)比较,差异有统计学意义(P< 0.05); 基因型频率的相对风险分析发现,等位基因G携带者患腰椎间盘突出症的风险是C携带者的1.617倍(95%CI:1.252 ~ 2.087,P< 0.001)。IL-6基因-174位点基因型在病例组(GG 92.52%、CG 7.48%)和对照组(GG 90.30%、CG 9.70%),差异无统计学意义(P= 0.304), 基因型频率的相对风险分析发现,等位基因G携带者患腰椎间盘突出症的风险与C携带者差异无统计学意义(P= 0.316)。IL-6-572C/G基因多态性分布与椎间盘退变MRI分级有相关性(P= 0.003)。结论IL-6-572C/G多态性与腰椎间盘突出症之间存在相互关系,其中G等位基因可能是腰椎间盘突出症发病的遗传易感基因。IL-6基因启动子的-174位点变异率极低,其多态性与腰椎间盘突出症的发病无明显相关性。IL-6-572C/G基因多态性与腰椎间盘退变程度存在相互关系,其G等位基因可能参与了椎间盘的退变进程。
黄向业, 张茜, 孙方利, 李金光, 赵静. 白细胞介素-6基因多态性与腰椎间盘突出症及腰椎退变程度的相关性[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(10): 734-739.
Xiangye HUANG, Qian ZHANG, Fangli SUN, Jinguang LI, Jing ZHAO. Association of IL-6 gene polymorphism with lumbar disc herniation and intervertebral disc degeneration[J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2022, 43(10): 734-739.
基本资料 | 病例组 | 对照组 | t/
|
P |
---|---|---|---|---|
年龄(岁) | 43.89 ± 9.21 | 42.51 ± 10.03 | 1.866 | 0.062 |
性别(男/女) | 208/113 | 230/131 | 0.087 | 0.768 |
BMI(kg/m2) | 24.28 ± 1.08 | 24.31 ± 1.95 | -0.256 | 0.798 |
SI ≥ 100 | 122/38.12 | 146/40.32 | 0.423 | 0.515 |
表1受试者基线资料[xˉ ± s, n(%)]
基本资料 | 病例组 | 对照组 | t/
|
P |
---|---|---|---|---|
年龄(岁) | 43.89 ± 9.21 | 42.51 ± 10.03 | 1.866 | 0.062 |
性别(男/女) | 208/113 | 230/131 | 0.087 | 0.768 |
BMI(kg/m2) | 24.28 ± 1.08 | 24.31 ± 1.95 | -0.256 | 0.798 |
SI ≥ 100 | 122/38.12 | 146/40.32 | 0.423 | 0.515 |
组别 | n | 基因型频率 | 等位基因频率 | ||||
---|---|---|---|---|---|---|---|
CC | CG | GG | C | G | |||
病例组 | 321 | 166(51.71) | 136(42.37) | 19(5.92) | 468(72.90) | 174(27.10) | |
对照组 | 361 | 232(64.27) | 123(34.07) | 6(1.66) | 587(81.30) | 135(18.70) | |
χ2 | 16.066 | 13.700 | |||||
P | < 0.001 | < 0.001 | |||||
OR(95%CI) | 1.000 | 1.545(1.128 ~ 2.117) | 4.426(1.730 ~ 11.321) | 1.000 | 1.617(1.252 ~ 2.087) |
表2病例组与对照组IL-6-572C/G基因型、等位基因分布频率差异性和相对风险分析[n(%)]
组别 | n | 基因型频率 | 等位基因频率 | ||||
---|---|---|---|---|---|---|---|
CC | CG | GG | C | G | |||
病例组 | 321 | 166(51.71) | 136(42.37) | 19(5.92) | 468(72.90) | 174(27.10) | |
对照组 | 361 | 232(64.27) | 123(34.07) | 6(1.66) | 587(81.30) | 135(18.70) | |
χ2 | 16.066 | 13.700 | |||||
P | < 0.001 | < 0.001 | |||||
OR(95%CI) | 1.000 | 1.545(1.128 ~ 2.117) | 4.426(1.730 ~ 11.321) | 1.000 | 1.617(1.252 ~ 2.087) |
组别 | n | 基因型频率 | 等位基因频率 | |||
---|---|---|---|---|---|---|
GG | CG | G | C | |||
病例组 | 321 | 297(92.52) | 24(7.48) | 618(96.26) | 24(3.74) | |
对照组 | 361 | 326(90.30) | 35(9.70) | 687(95.15) | 35(4.85) | |
χ2 | 1.058 | 1.011 | ||||
P | 0.304 | 0.315 | ||||
OR(95%CI) | 1.000 | 0.753(0.437 ~ 1.295) | 1.000 | 0.911(0.448 ~ 1.296) |
表3病例组与对照组IL-6-174 G/C基因型、等位基因分布频率差异性和相对风险分析[n(%)]
组别 | n | 基因型频率 | 等位基因频率 | |||
---|---|---|---|---|---|---|
GG | CG | G | C | |||
病例组 | 321 | 297(92.52) | 24(7.48) | 618(96.26) | 24(3.74) | |
对照组 | 361 | 326(90.30) | 35(9.70) | 687(95.15) | 35(4.85) | |
χ2 | 1.058 | 1.011 | ||||
P | 0.304 | 0.315 | ||||
OR(95%CI) | 1.000 | 0.753(0.437 ~ 1.295) | 1.000 | 0.911(0.448 ~ 1.296) |
基因型 | MRI分级 | ||||
---|---|---|---|---|---|
0级 | 1级 | 2级 | 3级 | 4级 | |
合计 | 4(1.24) | 19(5.92) | 101(31.46) | 108(33.64) | 89(27.74) |
CC(n= 166) | 2(1.20) | 11(6.63) | 68(40.96) | 48(28.92) | 37(22.29) |
CG(n= 136) | 1(0.74) | 6(4.41) | 30(22.06) | 56(41.18) | 43(31.62) |
GG(n= 19) | 1(5.26) | 2(10.53) | 3(15.79) | 4(21.05) | 9(47.37) |
表4321例腰椎间盘突出症患者IL-6-572C/G基因多态性与椎间盘退变程度的关系[n (%)]
基因型 | MRI分级 | ||||
---|---|---|---|---|---|
0级 | 1级 | 2级 | 3级 | 4级 | |
合计 | 4(1.24) | 19(5.92) | 101(31.46) | 108(33.64) | 89(27.74) |
CC(n= 166) | 2(1.20) | 11(6.63) | 68(40.96) | 48(28.92) | 37(22.29) |
CG(n= 136) | 1(0.74) | 6(4.41) | 30(22.06) | 56(41.18) | 43(31.62) |
GG(n= 19) | 1(5.26) | 2(10.53) | 3(15.79) | 4(21.05) | 9(47.37) |
基因型 | 病例组的MRI分级 | ||||
---|---|---|---|---|---|
0级 | 1级 | 2级 | 3级 | 4级 | |
合计 | 3(0.93) | 18(5.61) | 92(28.66) | 107(33.33) | 101(31.46) |
CG(n= 24) | 0(0) | 2(8.33) | 6(25.00) | 9(37.50) | 7(29.17) |
GG(n= 297) | 3(1.01) | 16(5.39) | 86(28.95) | 98(33.00) | 94(31.65) |
表5321例患者IL-6-174G/C基因多态性与椎间盘退变程度的关系[n (%)]
基因型 | 病例组的MRI分级 | ||||
---|---|---|---|---|---|
0级 | 1级 | 2级 | 3级 | 4级 | |
合计 | 3(0.93) | 18(5.61) | 92(28.66) | 107(33.33) | 101(31.46) |
CG(n= 24) | 0(0) | 2(8.33) | 6(25.00) | 9(37.50) | 7(29.17) |
GG(n= 297) | 3(1.01) | 16(5.39) | 86(28.95) | 98(33.00) | 94(31.65) |
1 | Rustenburg CME, Faraj SSA, Ket JCF, et al. Prognostic factors in the progression of intervertebral disc degeneration: which patient should be targeted with regenerative therapies?[J]. JOR Spine, 2019, 2(3): e1063. |
2 | Shiri R, Karppinen J, Leino-Arjas P, et al. Cardiovascular and lifestyle risk factors in lumbar radicular pain or clinically defined sciatica: a systematic review[J]. Eur Spine J, 2007, 16(12): 2043. |
3 | Munir S, Rade M, Määttä JH, et al. Intervertebral disc biology: genetic basis of disc degeneration[J]. Curr Mol Biol Rep, 2018, 4(4): 143. |
4 | Kawaguchi Y. Genetic background of degenerative disc disease in the lumbar spine[J]. Spine Surg Relat Res, 2018, 2(2): 98. |
5 | Violante FS, Zompatori M, Lovreglio P, et al. Is age more than manual material handling associated with lumbar vertebral body and disc changes? A cross-sectional multicentre MRI study[J]. BMJ Open, 2019, 9(9): e029657. |
6 | Li Y, Cao L, Li J, et al. Influence of microgravity-induced intervertebral disc degeneration of rats on expression levels of p53/p16 and proinflammatory factors[J]. Exp Ther Med, 2019, 17(2): 1367. |
7 | Molinos M, Almeida CR, Caldeira J, et al. Inflammation in intervertebral disc degeneration and regeneration[J]. J R Soc Interface, 2015, 12(108): 20150429. |
8 | Krupkova O, Sadowska A, Kameda T, et al. p38 MAPK facilitates crosstalk between endoplasmic reticulum stress and IL-6 release in the intervertebral disc[J]. Front Immunol, 2018, 9: 1706. |
9 | Xu SD, Ge BF, Xu YK. 标题为空[M]. Bejing: People's Militavy Medical Press, 2005. |
10 | 李小川, 吕刚, 金明熙, 等. 胰岛素样生长因子1抑制人椎间盘细胞凋亡及促进基质代谢的研究[J]. 中华实验外科杂志, 2004, 21(7): 880. |
11 | Xu HY. Obesity and metabolic inflammation[J]. Drug Discov Today Dis Mech, 2013, 10(1/2): e21. . |
12 | Curti ML, Pires MM, Barros CR, et al. Associations of the TNF-alpha -308 G/A, IL6 -174 G/C and AdipoQ 45 T/G polymorphisms with inflammatory and metabolic responses to lifestyle intervention in Brazilians at high cardiometabolic risk[J]. Diabetol Metab Syndr, 2012, 4(1): 49. |
13 | Lei SF, Liu YZ, Deng FY, et al. Association and linkage analyses of interleukin-6 gene 634C/G polymorphism and bone phenotypes in Chinese[J]. J Bone Miner Metab, 2005, 23(4): 323. |
14 | Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis[J]. J Clin Invest, 1998, 102(7): 1369. |
15 | Yuan HY, Tang Y, Liang YX, et al. Matrix metalloproteinase-3 and vitamin d receptor genetic polymorphisms, and their interactions with occupational exposure in lumbar disc degeneration[J]. J Occup Health, 2010, 52(1): 23. |
[1] | 谷千江.老年腰椎间盘突出症患者术前MRI特征与PELD术后疗效的相关性[J]. betway必威登陆网址 (betway.com )学报, 2021, 42(3): 176-180. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||